Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) consisting of 44 amino acids. It is structurally modified to improve stability and resistance to enzymatic degradation in laboratory settings.
In research environments, tesamorelin is studied for its interaction with GHRH receptors and downstream signaling pathways involved in growth hormone regulation. Its defined peptide sequence and receptor specificity have made it a compound of interest in experimental models examining endocrine signaling mechanisms.
For research purposes only. Not for human consumption.
|
Specification
|
Detail
|
|
Compound Name
|
Tesamorelin
|
|
Classification
|
Synthetic GHRH analogue peptide
|
|
Molecular Formula
|
C₂₂₁H₃₄₂N₄₆O₆₈
|
|
Molecular Weight
|
~5,135.9 g/mol
|
|
Amino Acid Length
|
44 amino acids
|
|
Peptide Sequence
|
Modified GHRH analogue
|
|
Purity
|
≥99% (HPLC verified)
|
|
Form
|
Lyophilized powder
|
|
Quantity
|
10 mg per vial
|
|
Solubility
|
Soluble in aqueous solutions (research handling)
|
|
Testing
|
HPLC / MS
|
|
COA
|
Available per batch
|
|
Storage
|
Store refrigerated (2–8°C) or frozen for long-term stability
|
